Ignite Creation Date:
2024-05-06 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03136653
Status:
COMPLETED
Last Update Posted:
2021-08-25
First Post:
2017-04-18
Brief Title:
A Phase 2 Trial of MP0250 Plus Bortezomib Dexamethasone in Patients With Multiple Myeloma
Sponsor:
Molecular Partners AG
Organization:
Molecular Partners AG
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-23
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-18
First Submit QC Date:
April 27 2017
Study First Post Date:
2017-05-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-19
Last Update Post Date:
2021-08-25
Last Update Post Date Type:
ACTUAL